During the active phase of the experiment (conducted for 2 months), patients from group A received tamsulosin 0.4 mg/day once and solifenacin at a double dose of 20 mg/day once, patients from group B received tamsulosin 0.4 mg/day and solifenacin in a standard dose of 10 mg/day once, patients from group C received a placebo.
The text above was approved for publishing by the original author.
받은편지함으로 가서 저희가 보낸 확인 링크를 눌러서 교정본을 받으세요. 더 많은 이메일을 교정받고 싶으시면:
또는